Skip to main content
Clinical Trials/RBR-8c62pnj
RBR-8c62pnj
Terminated
未知

Transcranial direct current stimulation on Pain, Disability and Quality of life in individuals with Chronic non-specific low back pain: a randomized clinical trial

niversidade Federal do Rio Grande do Norte0 sitesAugust 13, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversidade Federal do Rio Grande do Norte
Status
Terminated
Last Updated
last year

Overview

Brief Summary

Objective: to verify the effectiveness of tDCS in managing pain in individuals with CLBP; secondarily, test the hypothesis whether pain reduction is sufficient to reduce disability levels. Design: This is a randomized, double-blind controlled clinical trial. Participants were randomly allocated into two groups: simulated tDCS (n=17); Active tDCS (n=20). Setting: The study was developed at the Neuromuscular Performance Analysis Laboratory at the Federal University of Rio Grande do Norte (UFRN). Participants: The sample consisted of 37 individuals aged between 18 and 60 years with DLCNE. Intervention: Carried out twice a week for 10 weeks, totaling 20 sessions using the protocol (20 minutes, 2mA, applied to the dorsolateral prefrontal cortex (DLPFC). Outcome measures: pre and post intervention protocol assessments of: intensity pain threshold (VAS), pressure-LDP pain threshold (algometry) and disability (Roland-Morris Disability Questionnaire, Oswestry Disability Index and sit-stand test. Results: At the end of the study, the active tDCS group presented). a significant reduction in the level of pain compared to the sham group (p=0.026). On the other hand, there were no statistically significant differences between the groups for the LDP outcomes (L5D p=0.427; L5E p=0.842; L3D p=0.649; L3E p= 0.788), ODI (p=0.113), RMDQ (p=0.285) and sit-to-stand test (p= 0.726) Conclusion: Despite the low clinical relevance/effect size, tDCS reduces pain in individuals with DLCNE, without interfering with pressure pain levels and disability.

Registry
who.int
Start Date
August 13, 2024
End Date
February 18, 2023
Last Updated
last year
Study Type
Intervention

Investigators

Sponsor
niversidade Federal do Rio Grande do Norte

Eligibility Criteria

Inclusion Criteria

  • Age between 18 and 60 years; having non\-specific chronic low back pain; having an average pain score greater than or equal to 4/10 on a numeric rating scale

Exclusion Criteria

  • Have specific spinal pathology (tumor, spondylolisthesis, fracture, herniated disc, etc.); nerve root pain; coexistence of major muscular, joint, neurological, or psychiatric conditions; having undergone back surgery; perform some treatment for non\-specific chronic low back pain concomitantly with the study; making chronic use of analgesic opioids; present contraindications for tDCS; diabetes mellitus; uncontrolled hypertension; severe cardiovascular and/or pulmonary disease; pregnancy; malignant tumors

Outcomes

Primary Outcomes

Not specified

Similar Trials